Sriaomics

RNAi Therapeutics Focused Sirnaomics Closes $47 Million Series C Round
CP Wire
Fri, 04/26/19 - 10:06 am
Sriaomics
STP705
cholangiocarcinoma
hepatocellular carcinoma
RNAi
RNAi Therapeutics Focused Sirnaomics Closes $47 Million Series C Round
Fri, 04/26/19 - 10:01 am
Sriaomics
STP705
cholangiocarcinoma
hepatocellular carcinoma